3D printed drugs are medicines that are designed using 3D printing technology to customize them for patients in safe and effective manner. These drugs possess unitary porous structural design that readily dissolve in the mouth, which prevent high-dosage medicines from being swallowed intact. Therefore, this type of medicine is useful for patients having swallowing difficulties such as children, elderly, and those ailing with Alzheimer’s disease, stroke complications, head or neck tumors, and other neurological disabilities.
Read Report Overview - https://www.transparencymarketresearch.com/3d-printed-drugs-market.html
Spritam (levetiracetam) tablets were the first 3D printed drug that received approval from the U.S. Food and Drug Administration (FDA). These were developed by Aprecia Pharmaceuticals. However, after Spritam’s approval, various 3D printed implants and materials that likely to be deemed acceptable by FDA for usage in the medicine industry; however, no other drugs have been announced with the approval.
Factors driving the 3D printed drugs market include rise in demand of rapid soluble drugs, increase in elderly population, rise in rate of adoption of personalized drugs, increase in production of combination medicine, and high rate of adoption of 3D printing technology. Additionally, rampant technological advancements, rise in awareness about 3D printing, and improvements in the health care infrastructure are expected to propel the 3D printed drugs market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59043
However, factors such as antagonistic effects pertaining to the use of these drugs, dearth of government regulations linked to these drugs, and usage of 3D printing to develop illegal drugs are estimated to hamper the market. Introduction of 3D printed drugs by several market players in developing nations and rise in health care investment in emerging countries are anticipated to create opportunities in the market during the forecast period.
Based on application, the global 3D printed drugs market can be classified into orthopedic, hearing & audibility aid, medical implants, dental, neurology and others. The neurology segment is expected to account for a major share of the global market. In terms of region, the global 3D printed drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for leading share of the global market in 2017.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=59043
Asia Pacific is expected to account for a major share of the market during the forecast period. Growth of the pharmaceutical industry in this region due to rise in GDP is a major factor propelling the market. Additionally, rise in rate of adoption of advanced health care techniques by consumers owing to the increase in disposable income is expected to propel the market in Asia Pacific.
Major players operating in the global 3D printed drugs market include 3D Printer Drug Machine, Aprecia Pharmaceuticals, Hewlett Packard Caribe, BV, LLC, GlaxoSmithKline Plc. and FabRx Ltd. FabRx Ltd. Technologies Inc., Aprecia Pharmaceuticals, LLC. are the only existing players of global 3D printed drugs market and GlaxoSmithKline (GSK) is measured to be a potential player as the organization is planning to invest significantly in this industry.
Make an Enquiry before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=59043
Organizations involved in research pertaining to 3D printed drugs are UCL School of Pharmacy, University of Glasgow, University College London, The University of Nottingham, and National University of Singapore.
More Trending Reports by Transparency Market Research –
Multiple Sclerosis Drugs Market: https://www.transparencymarketresearch.com/multiple-sclerosis-drugs.html
Cholesterol Lowering Drugs Market: https://www.transparencymarketresearch.com/cholesterol-lowering-drugs-market.html
Women’s Health Diagnostics Market: https://www.transparencymarketresearch.com/womens-health-diagnostics-market.html
Traveler’s Diarrhea Treatment Market: https://www.transparencymarketresearch.com/travelers-diarrhea-market.html
Hereditary Angioedema Treatment Market: https://www.transparencymarketresearch.com/hereditary-angioedema-treatment-market.html
Biological Imaging Reagents Market: https://www.transparencymarketresearch.com/biological-imaging-reagents-market.html
Point-of-Care Coagulation Testing Devices Market: https://www.transparencymarketresearch.com/point-of-care-coagulation-testing-market.html
IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: https://www.transparencymarketresearch.com/inflammatory-bowel-disease.html
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
It provides information on the market’s essential aspects such as top participants, factors driving 3D Printed Drugs market growth, precise estimation of the 3D Printed Drugs market size, upcoming trends, changes in consumer behavioral pattern, market’s competitive landscape, key market vendors, and other market features to gain an in-depth analysis of the market.
Additionally, the report is a compilation of both qualitative and quantitative assessment by industry experts, as well as industry participants across the value chain.
The report presents a broad assessment of the market and contains solicitous insights, historical data, and statistically supported and industry-validated market data.
The report offers market projections with the help of appropriate assumptions and methodologies.
The research report provides information as per the market segments such as geographies, products, technologies, applications, and industries.To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.kdmarketinsights.com/sample/3363 Global 3D Printed Drugs Market Segmentation Analysis:By Technique Type:Fused Deposition ModelingInkjet Printing InfantZip DoseDirect WritePowder Bed PrintingSelective Laser SinteringStereolithographyOthersBy Dosage Form:TabletsCapsulesMulti Drug ImplantNanoparticlesSolutionsOthersBy Scenario:Low Growth ScenarioModerate Growth ScenarioRapid Growth ScenarioBy Drugs:SpritamOthersBy Applications:NeurologyOrthopedicHearing and Audibility AidDentalMedical ImplantsOthersBy End-Users:HospitalsClinicsResearch LaboratoriesOthersKey vendors engaged in the 3D Printed Drugs market and covered in this report:The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the 3D Printed Drugs market.
The report also predicts the influence of different industry aspects on the 3D Printed Drugs market segments and regions.Researchers also carry out a comprehensive analysis of the recent regulatory changes and their impact on the competitive landscape of the industry.
